122 related articles for article (PubMed ID: 7615284)
1. High pH reduces DNA damage caused by bile from patients with familial adenomatous polyposis: antacids may attenuate duodenal polyposis.
Scates DK; Venitt S; Phillips RK; Spigelman AD
Gut; 1995 Jun; 36(6):918-21. PubMed ID: 7615284
[TBL] [Abstract][Full Text] [Related]
2. DNA adducts, detected by 32P-postlabelling, in DNA treated in vitro with bile from patients with familial adenomatous polyposis and from unaffected controls.
Scates DK; Spigelman AD; Nugent KP; Phillips RK; Venitt S
Carcinogenesis; 1993 Jun; 14(6):1107-10. PubMed ID: 8389670
[TBL] [Abstract][Full Text] [Related]
3. 32P-postlabelling studies of target tissues and bile from patients with familial adenomatous polyposis and from unaffected controls.
Scates DK; Spigelman AD; Phillips RK; Venitt S
IARC Sci Publ; 1993; (124):357-64. PubMed ID: 8225507
[TBL] [Abstract][Full Text] [Related]
4. Differences in the levels and pattern of DNA-adduct labelling in human cell lines MCL-5 and CCRF, proficient or deficient in carcinogen-metabolism, treated in vitro with bile from familial adenomatous polyposis patients and from unaffected controls.
Scates DK; Spigelman AD; Phillips RK; Venitt S
Carcinogenesis; 1996 Apr; 17(4):707-13. PubMed ID: 8625481
[TBL] [Abstract][Full Text] [Related]
5. DNA adducts, detected by 32P-postlabelling, in the foregut of patients with familial adenomatous polyposis and in unaffected controls.
Spigelman AD; Scates DK; Venitt S; Phillips RK
Carcinogenesis; 1991 Sep; 12(9):1727-32. PubMed ID: 1654227
[TBL] [Abstract][Full Text] [Related]
6. The use of 32P-postlabelling in studies of the nature and origin of DNA adducts formed by bile from patients with familial adenomatous polyposis and from normal patients.
Scates DK; Spigelman AD; Phillips RK; Venitt S
Mutat Res; 1997 Aug; 378(1-2):113-25. PubMed ID: 9288890
[TBL] [Abstract][Full Text] [Related]
7. DNA adducts detected by 32P-postlabelling, in the intestine of rats given bile from patients with familial adenomatous polyposis and from unaffected controls.
Scates DK; Spigelman AD; Phillips RK; Venitt S
Carcinogenesis; 1992 Apr; 13(4):731-5. PubMed ID: 1315631
[TBL] [Abstract][Full Text] [Related]
8. Randomized, placebo-controlled trial of gastric acid-lowering therapy on duodenal polyposis and relative adduct labeling in familial adenomatous polyposis.
Wallace MH; Forbes A; Beveridge IG; Spigelman AD; Hewer A; Venitt S; Phillips RK
Dis Colon Rectum; 2001 Nov; 44(11):1585-9. PubMed ID: 11711728
[TBL] [Abstract][Full Text] [Related]
9. Bile acids do not form adducts when incubated with DNA in vitro.
Scates DK; Spigelman AD; Venitt S
Carcinogenesis; 1994 Dec; 15(12):2945-8. PubMed ID: 8001260
[TBL] [Abstract][Full Text] [Related]
10. In vitro model for liposome-mediated adenomatous polyposis coli gene transfer in a duodenal model.
Lee J; Hargest R; Wasan H; Phillips RK
Dis Colon Rectum; 2004 Feb; 47(2):219-26. PubMed ID: 15043293
[TBL] [Abstract][Full Text] [Related]
11. Mutagenicity of bile and duodenal adenomas in familial adenomatous polyposis.
Spigelman AD; Crofton-Sleigh C; Venitt S; Phillips RK
Br J Surg; 1990 Aug; 77(8):878-81. PubMed ID: 2168232
[TBL] [Abstract][Full Text] [Related]
12. The impact of chromoendoscopy for surveillance of the duodenum in patients with MUTYH-associated polyposis and familial adenomatous polyposis.
Hurley JJ; Thomas LE; Walton SJ; Thomas-Gibson S; Haycock A; Suzuki N; Mort M; Williams G; Morgan M; Clark SK; Sampson JR; Dolwani S
Gastrointest Endosc; 2018 Oct; 88(4):665-673. PubMed ID: 29702101
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of promutagenic etheno-DNA adducts in colonic polyps of FAP patients.
Schmid K; Nair J; Winde G; Velic I; Bartsch H
Int J Cancer; 2000 Jul; 87(1):1-4. PubMed ID: 10861445
[TBL] [Abstract][Full Text] [Related]
14. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
Brosens LA; Iacobuzio-Donahue CA; Keller JJ; Hustinx SR; Carvalho R; Morsink FH; Hylind LM; Offerhaus GJ; Giardiello FM; Goggins M
Clin Cancer Res; 2005 Jun; 11(11):4090-6. PubMed ID: 15930344
[TBL] [Abstract][Full Text] [Related]
15. Familial segregation in the occurrence and severity of periampullary neoplasms in familial adenomatous polyposis.
Sanabria JR; Croxford R; Berk TC; Cohen Z; Bapat BV; Gallinger S
Am J Surg; 1996 Jan; 171(1):136-40; discussion 140-1. PubMed ID: 8554128
[TBL] [Abstract][Full Text] [Related]
16. Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls.
van Heumen BW; Roelofs HM; te Morsche RH; Nagengast FM; Peters WH
Orphanet J Rare Dis; 2013 Nov; 8():181. PubMed ID: 24245549
[TBL] [Abstract][Full Text] [Related]
17. Gene Expression Changes Accompanying the Duodenal Adenoma-Carcinoma Sequence in Familial Adenomatous Polyposis.
Thiruvengadam SS; OʼMalley M; LaGuardia L; Lopez R; Wang Z; Shadrach BL; Chen Y; Li C; Veigl ML; Barnholtz-Sloan JS; Pai RK; Church JM; Kalady MF; Walsh RM; Burke CA
Clin Transl Gastroenterol; 2019 Jun; 10(6):e00053. PubMed ID: 31211760
[TBL] [Abstract][Full Text] [Related]
18. Capsule endoscopy is useful and safe for small-bowel surveillance in familial adenomatous polyposis.
Iaquinto G; Fornasarig M; Quaia M; Giardullo N; D'Onofrio V; Iaquinto S; Di Bella S; Cannizzaro R
Gastrointest Endosc; 2008 Jan; 67(1):61-7. PubMed ID: 18155426
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal and methylation alterations in sporadic and familial adenomatous polyposis-related duodenal carcinomas.
Berkhout M; Nagtegaal ID; Cornelissen SJ; Dekkers MM; van de Molengraft FJ; Peters WH; Nagengast FM; van Krieken JH; Jeuken JW
Mod Pathol; 2007 Dec; 20(12):1253-62. PubMed ID: 17873900
[TBL] [Abstract][Full Text] [Related]
20. Preventative strategies for periampullary tumours in FAP.
Wallace MH; Phillips RK
Ann Oncol; 1999; 10 Suppl 4():201-3. PubMed ID: 10436822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
